Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

AI plays a crucial role in identifying early-stage cancers, facilitating prompt interventions that enhance survival prospects. Cancer's intricate nature means that each type carries distinct characteristics, packed with extensive data that requires thorough analysis. This is where AI excels, leveraging its capabilities to process complex information, ultimately revealing insights that can significantly aid in cancer treatment strategies. Equipped with precise and relevant data, we take proactive steps in our battle against cancer. By utilizing AI, we are poised to make substantial strides in overcoming this disease. Our AI technology is designed to detect early-stage cancer with remarkable accuracy, achieving detection rates between 97-99%. It proficiently identifies ten of the most prevalent abnormalities found in chest x-rays, thus enhancing one of the most fundamental diagnostic tools. This innovation not only streamlines the radiology workflow but also alleviates the workload for radiologists. Lunit INSIGHT CXR successfully encompasses a wide range of findings, ensuring that we are prepared to tackle the challenges presented by cancer detection and treatment. The future of cancer care looks promising with AI at the forefront of these advancements.

Description

See-Mode Technologies is a MedTech firm focused on utilizing AI to enhance ultrasound reporting, thereby boosting both diagnostic accuracy and operational efficiency. Their innovative platform swiftly analyzes ultrasound images of the thyroid and breast, resulting in rapid and precise radiology reports. By identifying, measuring, and characterizing nodules, See-Mode produces a comprehensive TI-RADS sonographer worksheet along with initial impressions for radiologists. In the realm of breast imaging, the software not only detects lesions but also automates the BI-RADS reporting process, offering detailed insights into lesion characteristics and levels of suspicion. This advanced technology minimizes inter-operator variability and reduces the likelihood of reporting errors, ultimately strengthening diagnostic confidence and ensuring consistency. By streamlining the reporting process, See-Mode facilitates more informed clinical decisions, which can lead to better patient outcomes.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Lunit

Country

United States

Website

www.lunit.io/en

Vendor Details

Company Name

See-Mode

Founded

2017

Country

Australia

Website

www.see-mode.com

Product Features

Product Features

Alternatives

qCT Reviews

qCT

Qure.ai

Alternatives

OMS Diagnostics Reviews

OMS Diagnostics

Objective Medical Systems
The Galen Platform Reviews

The Galen Platform

Ibex Medical Analytics
Oncora Reviews

Oncora

Oncora Medical
Join AI Reviews

Join AI

Miracle Advance Technologies